High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy

Perng R.-P.CHIH-HSIN YANGChen Y.-M.Chang G.-C.Lin M.-C.Hsieh R.-K.Chu N.-M.Lai R.-S.Su W.-C.Tsao C.-J.Hsia T.-C.Chen H.-C.Chen C.-H.Huang M.-S.Wang J.-L.Ho M.-L.Chung C.-Y.CHONG-JEN YUChang W.-C.Kuo H.-P.Yu C.-T.ZHONG-ZHE LINKao W.-Y.2022-06-272022-06-2720080169-5002https://www.scopus.com/inward/record.uri?eid=2-s2.0-52149092350&doi=10.1016%2fj.lungcan.2008.02.023&partnerID=40&md5=57d274dd86b5c9f50815ca8c4aefde11https://scholars.lib.ntu.edu.tw/handle/123456789/614505[SDGs]SDG3High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapyjournal article10.1016/j.lungcan.2008.02.023184237812-s2.0-52149092350